About KDDF
Greetings
Who We are
What We do
R&D Pipeline
Season 1 (2011-2020)
Season 2 (2021-2030)
Networks
Media Room
Photo & Video
Publications
News
Contact us
한국어
한국어
ENG
About KDDF
Greetings
Who We are
What We do
R&D Pipeline
Season 1 (2011-2020)
Season 2 (2021-2030)
Networks
Media Room
Photo & Video
Publications
News
Contact us
한국어
ENG
R&D Pipeline
Season 2 (2021-2030)
Season 1 (2011-2020)
Season 2 (2021-2030)
Season 2 (2021-2030)
Cardiovascular - Phase1 (1)
Modality
Indication
Targets
Stage
Company
Project No.
Detail
1
Antibody
Pulmonary hypertension
KARS1
Phase 1
Zymedi
RS-2023-00283541
BACK
